| Literature DB >> 31358818 |
Fernanda L Paganelli1, Misha Luyer2, C Marijn Hazelbag3, Hae-Won Uh3, Malbert R C Rogers1, Danielle Adriaans2, Roos-Marijn Berbers1,4, Antoni P A Hendrickx1, Marco C Viveen1, James A Groot1, Marc J M Bonten1, Ad C Fluit1, Rob J L Willems1, Helen L Leavis5.
Abstract
Bariatric surgery in morbid obesity, either through sleeve gastrectomy (SG) or Roux-Y gastric bypass (RYGB), leads to sustainable weight loss, improvement of metabolic disorders and changes in intestinal microbiota. Yet, the relationship between changes in gut microbiota, weight loss and surgical procedure remains incompletely understood. We determined temporal changes in microbiota composition in 45 obese patients undergoing crash diet followed by SG (n = 22) or RYGB (n = 23). Intestinal microbiota composition was determined before intervention (baseline, S1), 2 weeks after crash diet (S2), and 1 week (S3), 3 months (S4) and 6 months (S5) after surgery. Relative to S1, the microbial diversity index declined at S2 and S3 (p < 0.05), and gradually returned to baseline levels at S5. Rikenellaceae relative abundance increased and Ruminococcaceae and Streptococcaceae abundance decreased at S2 (p < 0.05). At S3, Bifidobacteriaceae abundance decreased, whereas those of Streptococcaceae and Enterobacteriaceae increased (p < 0.05). Increased weight loss between S3-S5 was not associated with major changes in microbiota composition. No significant differences appeared between both surgical procedures. In conclusion, undergoing a crash diet and bariatric surgery were associated with an immediate but temporary decline in microbial diversity, with immediate and permanent changes in microbiota composition, independent of surgery type.Entities:
Mesh:
Year: 2019 PMID: 31358818 PMCID: PMC6662812 DOI: 10.1038/s41598-019-47332-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical parameters analyzed at baseline (S1) and 6 months after surgery (S5).
| SG | RYGB | |
|---|---|---|
| Gender | 77.27% (female) | 91.30% (female) |
| Age (years) | 43.5 ± 12.03 | 44 ± 9.29 |
| Type of surgery | 48.80% | 51.10% |
| Proton pump inhibitors | 23.80% | 26.08% |
| Diabetes Mellitus | 9.09% | 8.69% |
| BMI (kg/m2) S1 | 42.9 ± 6.56 | 43 ± 4.13 |
| BMI (kg/m2) S2 | 38.91 ± 6.18 | 40.57 ± 4.19 |
| BMI (kg/m2) S4 | 33.69 ± 5.51 | 35.07 ± 4.03 |
| BMI (kg/m2) S5 | 30.81 ± 5.35* | 31.52 ± 3.86* |
| vitD (nmol/l) S1 | 40 ± 16.39 | 42 ± 15.24 |
| vitD (nmol/l) S5 | 73 ± 14.39* | 73 ± 23.16* |
| vitB6 (nmol/l) S1 | 74 ± 33.34 | 66 ± 37.53 |
| vitB6 (nmol/l) S5 | 104 ± 54.66 | 105 ± 46.99* |
| Cholesterol (mmol/l) S1 | 5.40 ± 0.88 | 5.47 ± 1.08 |
| Cholesterol (mmol/l) S5 | 4.93 ± 0.68 | 4.05 ± 0.78* |
| Bilirubin (µmol/ml) S1 | 5.70 ± 6.27 | 5.60 ± 2.44 |
| Bilirubin (µmol/ml) S5 | 9.30 ± 6.53 | 7.25 ± 4.08 |
| HbA1c (mmol/mol) S1 | 39 ± 11.8 | 38 ± 5.48 |
| HbA1c (mmol/mol) S5 | 32.50 ± 3.91 | 34 ± 4.35* |
| Iron (µmol/l) S1 | 10 ± 6.17 | 12 ± 5.34 |
| Iron (µmol/l) S5 | 17 ± 8.27 | 16.50 ± 4.88 |
| Ferritin (µg/l) S1 | 73 ± 232.83 | 84 ± 119.09 |
| Ferritin (µg/l) S5 | 114 ± 197.36 | 108 ± 114.65 |
| Folate (mmol/l) S1 | 15 ± 6.71 | 15 ± 5.94 |
| Folate (mmol/l) S5 | 16 ± 6.11 | 31.50 ± 10.06* |
Asterisk indicates significant differences between S1 and S5 (p < 0.05) calculated by t-test with false discovery rate (FDR) multiple testing correction.
Reference values. BMI: <18.5 (underweight), 18.5–24.9 (normal weight), 25–29.9 (overweight), >30 (obese). VitD: 50–100 nmol/l. VitB6: 34–156 nmol/l. Cholesterol: 3.5–6.5 nmol/l. Bilirubin: 3–21 µmol/l. HbA1c: 20–42 mmol/l. Iron: 8–33 µmol/l (male), 5–30 µmol/l (female). Ferritin: 25–250 µg/l (male), 20–150 µg/l (female). Folate: > 6.8 mmol/l.
Figure 1Observed and estimated richness of gut microbiota at different time points during the bariatric surgery procedure. (A) Shannon diversity index estimated a decrease in bacterial richness at S2 and S3. (B) Rarefaction curves showed a reduction in bacterial richness at S2 and S3. (C) Principal component analysis (PCA) plot of similarity between the samples; each dot represents 1 sample, each color a different time point. S1. before surgery (red); S2. after 2 weeks of crash diet (orange); S3. 1 week after surgery (yellow); S4. 3 months after surgery (light blue); S5. 6 months after surgery (dark blue).
Figure 2Relative abundance of bacterial families in the gut microbiota at the five time points analyzed. (A–G) Boxplots show the average relative abundance of 7 families that significantly changed between 2 different time points. (A) Streptococcaceae. (B) Enterobacteriaceae. (C) Bifidobacteriaceae. (D) Ruminococcaceae. (E) Rikenellaceae. (F) Veillonellaceae. (G) O_Clostridiales_f_others. H. Relative abundance of all families identified at the different time points. Significant families are represented in the same color. Asterisk (in red) indicates significant fold change differences (p < 0,05) analyzed by ANCOM.
Figure 3(A–C). Principal coordinate analysis (PCoA) plots comparing beta diversity of Sleeve Gastrectomy (SG) versus Roux-Y Gastric bypass (RYGB) surgery at baseline (S1) (A) 1 week after surgery (S3) (B) and 6 months after surgery (S5). (C) SG is indicated in red, RYGB is indicated in blue. (D) Relative abundance of bacterial families in the gut microbiota at the five time points analyzed in SG versus RYGB surgery.
Figure 4Association between clinical parameters and family taxa calculated based on the difference between 6 months after surgery (S6) and baseline (S1). Significant associations (false discovery rate (FDR) adjusted p-value < 0.05) are indicated with an “x”. The red color indicates a positive association and the blue color a negative association. HbA1c, glycated hemoglobin; VitD, vitamin D; VitB6, vitamin B6.